Hat mitgewirkt an:
-
STAT3 Single Nucleotide Polymorphism rs4796793 SNP Does Not Correlate with Response to Adjuvant IFNα Therapy in Stage III Melanoma Patients
-
Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma
-
Willingness to pay for a cure of low-risk melanoma patients in Germany
-
Dabrafenib und Trametinib : Kombinationstherapie bei erwachsenen Patienten mit einer BRAF-V600-Mutation